Skip to main content
Plastic and Reconstructive Surgery Global Open logoLink to Plastic and Reconstructive Surgery Global Open
. 2021 Sep 9;9(9):e3778. doi: 10.1097/GOX.0000000000003778

Practical Review of the Management of Animal Bites

Andrei N Savu *, Anna R Schoenbrunner †,, Rachel Politi †,, Jeffrey E Janis ‡,
PMCID: PMC8432645  PMID: 34522565

Background:

Animal bites are common worldwide. Due to the plethora of animals, there are diverse pathogens with specific associated risks and treatment algorithms. It is crucial to understand these to develop and execute appropriate management plans. This practical review was designed to amalgamate the most common bites worldwide and synthesize data to help guide treatment plans.

Methods:

A PubMed literature search was performed focusing on the major animal bites. High-level studies were preferred and analyzed but lower-level studies were also used if high-level studies did not exist.

Results:

The tables presented in this article cover the pertinent information regarding the incidence, common presentation, initial treatment, and potential complications associated with bites from dogs, cats, horses, rodents, snakes, marine life, and spiders. Many of the pathogens associated with the bites are treatable with various and somewhat common antimicrobials, though some are less easy to access. Basic irrigation, debridement, and wound culture are common to almost every animal and should be the first step in treatment.

Conclusions:

Based on the current studies, the most important factor in treating animal bites is timely presentation to a medical facility and/or physician. It is critical that the offending animal be accurately identified to help guide medical and surgical algorithms, including specific antimicrobial treatment guided by the most commonly presenting pathogens specific to certain animals.

INTRODUCTION

Animal bites are a common indication for medical care both in the United States and worldwide, accounting for approximately 1% of emergency department visits and more than 50 million dollars in annual healthcare costs in the United States alone.1 Although the initial evaluation of a patient presenting with an animal bite follows a similar sequence, the precautions and subsequent management of various types of bites should be specific to the bite origin.1

The existing literature on animal bites reveals that various types of bites have different risks, management algorithms, and potential complications. Review and synthesis of the standing literature may assist in the comparison of various animal bites to better understand both the underlying commonalities of basic treatment and important clinical pearls that differentiate specific bites. Timely intervention is essential in mitigating symptoms and reducing complications.

This article will discuss the incidence, common presentation, treatment, and potential complications associated with the most frequent types of bites encountered. These bites include those of dogs, cats, horses, rodents, snakes, marine life, and spiders.

METHODS

Using the PubMed database, a literature search was performed with the inclusion criteria of English Language AND 1990-Current AND Humans for the following individual MESH terms: Bites and Stings, Dogs, Cats, Equidae, Sharks, Alligators and Crocodiles, Fish, Rodentia, Rats, Rabbits, Guinea Pigs, Mice, Snake Bites, Snakes, Spider Bites, and Spiders. The results were further screened manually to initially exclude those that were not accessible, beyond the scope of this article or not meeting level I or level II study criteria as described by the American Society of Plastic Surgeons.2 Level I studies (n = 68) were defined as therapeutic randomized controlled trial, high-quality prognostic prospective cohort studies or systematic reviews of these study types.2 Level II studies (n = 20) were defined as low-quality therapeutic randomized controlled trial, nonrandomized therapeutic prospective studies, low-quality prognostic prospective studies, prognostic retrospective cohort studies, or a systematic review of the described study types.2 For any topics in which this level of evidence was unattainable, lower-level resources were included (n = 3). The data were analyzed and overarching themes were synthesized to provide a scoping review on the topic of animal bites.

Dogs

Dog bites account for approximately 85%–90% of animal bites in the United States, with an estimated 800,000 of these bites presenting for medical attention annually.3 The most affected populations are male youths, particularly those with behaviors that elicit or trigger aggressive actions in dogs.4,5 Such behaviors include physically harassing the dog and trying to take the dog’s food. Injury rates have been shown to decrease with increasing age.4 Most bites are reported in the setting of warm weather, during the evening and in the home environment, with single-parent homes showing increased risk.68 Commonly implicated breeds include pit bulls, shih tzus, German shepherds, Dobermans, Alsatian mixes, and rottweilers.911

Age of the affected individual may stratify the presentation of bite wounds by incident location, severity, and body region.12 Children are more likely to suffer bites and bites of greater severity, as demonstrated in one study by a correlation of −0.80 between increasing age and bite frequency.13,14 Populations under the age of five are more likely to present with head and neck injuries, incurred indoors and with a familiar dog (often belonging to the family).14,15 Current data suggest that pit bulls are the most dangerous for children younger than 18, whereas dachshunds and shih tzus are possibly dangerous for children younger than 3 years.13,14 In contrast, adolescents and adults are more likely to suffer injuries to the extremities, occurring outdoors and more often by interactions with unfamiliar dogs.14,15 Dogs with larger teeth are expected to yield more crush injuries that lead to lacerations and superficial abrasions rather than puncture wounds, which are more common in smaller dogs.16

Treatment of dog bite wounds is largely predicated on the location of injury and time of presentation.17 The “risk” of the injury is based on the likeliness of infection and is dependent on the victim, species, depth, overall tissue destruction, joint involvement, and location of bite. High-risk bites are typically deeper and more destructive, whereas low-risk bites are neither deep nor destructive.18 Upper extremity wounds are more likely to require surgical intervention and most prone to develop infection.17 Additionally, patients presenting 1–2 days post bite carry a 3.5 and 7 times increase in the relative risk of hospitalization or surgery, respectively compared to patients presenting the same-day.17 All wounds, and in particular those requiring subsequent primary closure, should undergo high-pressure irrigation19 and debridement.16 Primary wound closure has been demonstrated to be superior for injuries in aesthetically sensitive areas such as the face as compared to healing by secondary intention.16 It remains controversial whether primary closure poses a slightly increased risk of infection, but most randomized clinical trials have concluded that infection rates for primary and secondary closures are equivalent at 40%.16,17,2022 All studies comparing modalities of treatment have demonstrated that primary closure yields faster healing and superior cosmetic outcomes, as quantified by reduced scar size and appearance.2022

Prophylactic antibiotic treatment of dog bite wounds remains controversial, but rabies postexposure prophylaxis (PEP) is largely unindicated in low-risk bites.23,24 In a meta-analysis of randomized trials, it was found that approximately 14 patients must be treated to prevent infection from one dog bite wound.25 Circumstances in which rabies PEP may be indicated include upper extremity bites in children, puncture wounds, and wounds those with a laceration length of greater than 3 cm.17,24,26 Rabies PEP may also be of use in residents and travelers of areas with endemic rabies disease, where Rabies PEP.27,28 Education of healthcare providers is crucial to the success of treatment.27,28 In one study conducted in Haryana, North India, PEP was known to only 18.8% of healthcare professionals (HCPs) and only 59% of HCPs were confident in managing dog bites.29 Other barriers to the success of rabies PEP include cost, failure of compliance to complete PEP, delay in medical presentation, and use of prehospital treatments, which is directly associated with a delay in seeking medical treatment.2934 Failure to comply with rabies PEP has been associated with location of residence, male sex, ages 15–49, time of year, and duration of PEP protocol.32 Likewise, delayed access to care has been associated with age older than 15 years, residence in rural areas, and the rainy season.34 Rabies infections following dog bites are most commonly cited in lower extremity injuries and associated with residence in developing countries, residence in rural areas, male gender, warm weather, and dry season.3437

Other common sequelae include lacerations, fractures, arterial injuries, amputations, and arthritis.38,39 Most sequelae are of cosmetic nature and associated with female gender, larger dog weight, and severity of dog bite injury.40 Children are 4.2 times more likely to sustain ocular injuries as well as facial trauma as compared to adults.41,42 Periocular injuries should be evaluated for canalicular laceration and fracture of periorbital and nasal bones, as these structures are commonly implicated.4143 Complications following facial injury include facial nerve damage, lacrimal duct damage, ptosis and ruptured globe, and blood loss requiring transfusion.41,42 More serious complications also reported include osteomyelitis, sepsis, neurological injuries, and death.38,39 Common pathogens and treatments are presented in Table 1.

Table 1.

Common Pathogens and Subsequent Treatment of Dog Bites

Pathogen Recommended Treatment Timing Route of Administration Dosage Notes
Pasteurella canis Beta lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults Aggressive broad-spectrum antibiotics used only if infection is advanced
Beta lactamase inhibitors44 (eg, tazobactam)
Aggressive broad-spectrum antibiotics44
Streptococci and Staphylococci Beta lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults
Beta lactamase inhibitors44 (eg, tazobactam)
Capnocytophaga canimorsus Beta lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults
Beta lactamase inhibitors44 (eg, tazobactam)

Cats

Cat bites also contribute a significant portion to the total of animal bites observed, with incidence varying significantly depending on location. For instance, New York City Emergency Department data report that cat bites constitute approximately 13% of all bites, second only behind dogs (70%),45 whereas in Dallas, Texas, it is 25%.46 The exact percentage varies between countries worldwide (Table 2).4650,53

Table 2.

Percentage of Bites Caused by Cats in Locations Worldwide

Location Observed Percentage of Bites Caused by Cats (%)
France47 16.8
Italy48 19.7
Spain49 8
Switzerland50 25
Turkey46 7.5
United States51,52 3–15

Environmental factors associated with increased bite incidence include high humidity and summer months.46,49,53 Cats represent a larger portion (89.4%) of provoked attacks as compared to dogs, with additional features of Siamese breed, female gender, and domestic status increasing the risk of attack.50,54 In contrast to dogs, cat bites are largely inflicted by the owner’s own cat regardless of age of the victim.55 Additional victim characteristics associated with increased prevalence include female gender and older age.26,48,50,53

Cat bites commonly present as a single puncture, often on the hand or arm (91%).49,56,57 Of hand injuries, the index finger is the most common site of injury (45%).57 Across all animal bites, nonpurulent wounds with lymphangitis are most associated with cats.58 Risk factors for subsequent hospitalization include smoking, immunocompromised state, location of bite over a joint or tendon sheath, and initial physical findings of erythema and swelling.59 The initial treatment of cat bite wounds is similar to dog bites, entailing irrigation,19 debridement, wound culture, and assessment of tetanus and rabies risk.51,52 However, the primary closure of cat bites is not recommended due to the deep penetrative nature and increased contamination rate associated with these wounds.51,60 Initial surgical debridement is of increased importance and in one study was shown to reduce the positive bacterial smear from 62% to 13% postprocedure.60 Plain radiographs should be obtained if bone or joint involvement is suspected.52 Lacerations may be closed after a waiting period of 4–5 days with elevation, immobilization, and intensive physiotherapy implemented in all hand bites.51,59

Complications of cat bites include wound infection, development of rabies infection, and lymphadenopathy (cat scratch fever).1,28,50,56 Wound infection following cat bites is of greatest concern, as it is more common following bites by cats (30.8%) than by dogs (8.5%).50,56,57 The microbiological profile of these bites is commonly a mixed aerobic and anaerobic infection (63%), with Pasteurella multocida being present in 70% of all infections.52,56,58,61 Pasteurella usually indicates symptoms often within 3 hours of attack.56,61 Infection often presents with cellulitis with accompanying erythema (89%), severe pain (83%), edema (77%), and fever (18%) within 3 hours of the biting incident.56,61 Tenosynovitis, arthritis, abscess, and septicemia have also been reported (18%), as well as osteomyelitis, pneumonia lung abscesses, and empyema.56,61 Common pathogens and treatments are presented in Table 3.

Table 3.

Common Pathogens and Subsequent Treatment of Cat Bites

Pathogen Recommended Treatment Timing Route of Administration Dosage Notes
Pasteurella multocida Beta-lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults Aggressive broad-spectrum antibiotics used only if infection is advanced
Beta-lactamase inhibitors44 (eg, tazobactam)
Aggressive broad-spectrum antibiotics
Staphylococci 61 Beta-lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults
Beta-lactamase inhibitors44 (eg, tazobactam)
Francisella tularnesis 62 Streptomycin 2 daily doses; one dose every 12 h Typically IM 30–40 mg/kg/d for children; 7.5–10 mg/kg/d for adults
Yersinia pestis 63 Streptomycin 2 daily doses; one dose every 12 h IM 30 mg/kg/d for children; 2 g/d for adults
Gentamicin
Sporothrix schenckii 64 Itraconazole 3 to 6 mo antibiotic treatment; 1 dose daily; 2 doses if patient is unresponsive Oral administration 200 mg Should not be administered to pregnant patients
Bartonella henselae 65 Azithromycin 1 d of a certain dosage and 4 d of a lesser dosage Oral administration 10 mg/kg/d 1 followed by 5 mg/kg for four more days for children; 500 mg/d 1 followed by 250 mg for 4 d for adults It should be noted that some infections do not require antibiotics, especially if it is a localized lymphadenopathy

IM, intramuscular.

Snakes66,67

Factors associated with increased snakebite prevalence include field labor, male gender, middle age, lower education status, low income, and residence in rural areas.66,6877 Associated environmental factors include monsoon season and evening hours.71,73,78,79 In the United States, increased biting rates have been reported in the locations of Texas, Florida, West Virginia, Oklahoma, and Louisiana.76

Presenting symptoms may be useful in determining appropriate treatment interventions.80 Isolated fang marks can indicate the presence of a venomous bite with a demonstrated sensitivity of 100% and positive predictive value of 89%. The presence of multiple scratches, on the other hand, has demonstrated a positive predictive value of 100% for nonvenomous bites.80 Symptoms largely include pain and swelling with accompanying erythema, ecchymosis, and paresthesia. Additional symptoms are described in Table 4.68,75,81

Table 4.

Symptoms Associated with Snake Bites

Additional Symptoms Occurrence (%)
Hemotoxicity 76.9
Local Reaction 9.6
Syncope 9
Neurotoxicity 4.5
Ptosis 4.5
Altered sensorium 4.5
Breathlessness 3.2
Diplopia 2
Oliguria 1.3
Dysarthria 0.6
Chest pain 0.6

Antivenom such as CroFab, which has been recognized as the first line over antivenin crotalidae polyadvent, is successful in the treatment of most bites.75,82,83 Additional protocol features should include removal of articles that may constrict limb swelling, maintenance of patent airway, and immobilization of bitten limb at a level below the heart to prevent systemic spread.82,84 Lack of education regarding proper snake bite management poses barriers to appropriate treatment administration and results in increased complication rates.8587 Antivenom administration has been reported with the rare occurrence of an immediate or delayed onset hypersensitivity reaction.88

A wide array of complications may ensue, including systemic, pulmonary, neurological, renal, and local wound manifestation.75,81,8991 These symptoms commonly include hemorrhagic blisters, pulmonary edema, compartment syndrome, cranial nerve paralysis, stroke, and shock.75,79,92 Sequelae including respiratory failure, dyspnea, systemic bleeding, sepsis, and shock have been documented as strongly associated with fatal outcomes.87 Common pathogens and treatments are presented in Table 5.

Table 5.

Common Pathogens and Subsequent Treatment of Snake Bites

Pathogen Recommended Treatment Timing Route of Administration Dosage Notes
Snake venom Antivenom such as CroFab Must be applied as quickly as possible Intravenous injection Dosage reports have shown to not cause significant change. Quick administration is more important Antivenom has been shown to be more effective
ACP
Gram negative Enterobacteriaceae and Enterococci93 Ciprofloxacin 2 doses daily; 1 dose every 12 h Typically oral 250–750 mg Enterobacteriaceae and Enterococci are very resistant to typical beta-lactam and beta-lactamase inhibitors which is why ciprofloxacin is used

ACP, antivenin crotalidae polyadvent.

Rodents

An estimated 20,000 rat bites occur in the United States annually.94 Those most affected are children under 5 years old.94,95 Biting incidents often occur in the home, during summer months and between the hours of midnight and 8 am.95 Clinical presentation is often on the face and hands.95 Common pathogens and treatments are presented in Table 6.

Table 6.

Common Pathogens and Subsequent Treatment of Rodent Bites

Pathogen Recommended Treatment Timing Route of Administration Dosage Notes
Pasteurella multocida Beta lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults Aggressive broad-spectrum antibiotics used only if infection is advanced
Beta lactamase inhibitors44 (eg, tazobactam)
Aggressive broad-spectrum antibiotics
Bacillus subtilis 96 Clindamycin97 3 to 4 times a day98 Liquid capsule; oral with water 8–12, 13–16, or 17–25 mg for children depending on the severity of the infection; 150–300 or 300–450 mg for more advanced infections for adults98 This organism has demonstrated significant sensitivity and resistance to many beta-lactams, thus they are to be avoided
Vancomycin99 2 times a day; 1 dose every 12 h IV injection 15 mg/kg
Alpha-Hemolytic Streptococcus Beta-lactam44 (eg, penicillin) 2 to 3 times a day with accompanying meal Typically oral administration 25–50 mg for children; 250–300 mg for adults There has been data showing growing resistance to beta-lactam antibiotics. Vancomycin is typically used if patient is unresponsive to beta-lactams or if infection is advanced44,99
Vancomycin99 2 times a day; 1 dose every 12 h99 IV injection 15 mg/kg
Francisella tularnesis 62 Streptomycin 2 daily doses; one dose every 12 h Typically IM 30–40 mg/kg/d for children; 7.5–10 mg/kg/d for adults
Rat bite fever: Streptobacillus moniliformis100 Penicillin G Children: 7 d of IV followed by 7 d of oral IV and/or oral 12–30 mg/kg/d for children + 25–50 mg/kg/d; 240–36 mg for adults with no oral addition Growing resistance to Penicillin G but not enough to justify treatment change, streptomycin and tetracycline also appear to be effective treatments
Adults: 7 d of IV
Rat bite fever: Spirillium minus100 Penicillin G Children: 7 d of IV followed by 7 d of Oral IV and/or oral 12–30 mg/kg/d for children + 25–50 mg/kg/d; 240–36 mg for adults with no oral addition
Adults: 7 days of IV

IM, intramuscular; IV, intravenous.

Horses

Although horse-related fatalities are more common, horse bites are rarely reported,101 with incidence varying by country. For example, horse bites have been reported to account for 17% of all bites in Turkey, doubling that of cat bites.46 Clinically, these injuries often present as tissue loss to the head and neck areas, followed by injury to the extremities and least often the trunk.101 Treatment should include cleaning with saline, rather than irrigation with antibiotic or iodine solution, in an effort to decrease potential tissue irritation.19,101 Following debridement, primary closure and surgical intervention are both potential treatment options, but primary closure is advised.101 Subsequent infection is rare, but has been reported in conjunction with osteomyelitis, and few complications have been described on follow-up to initial treatment.94,101 Common pathogens and treatments are presented in Table 7.

Table 7.

Common Pathogens and Subsequent Treatment of Alligator and Crocodile Bites

Pathogen Recommended Treatment Timing Route of Administration Dosage Notes
Pseudomonas aeruginosa 102,103 Piperacillin + tazobactam102,103 Piperacillin + tazobactam: 30-min injection periods every 6 h for mild infections, 6–8 h for severe infections IV Piperacillin + tazobactam: This bacteria has been shown to have increased resistance to many treatments such as the most common: ciprofloxacin. Studies have indicated debate on the appropriate treatment, but current consensus is beta-lactam treatment at the minimum and aminoglycoside can be additionally added, though with more side effects102,104
Mild: 3.375 g
Ciprofloxacin104 Severe: 4.5 g
Ciprofloxacin: 400 mg
Ciprofloxacin: 30-min injection periods every 8 h104
Aeromonas hydrophilia 105 Doxyclycline106 100 mg every 12 h for the first day followed by 50 mg every 12 h Oral 200 mg for the first day followed by 100 mg for the following days Avoid ampicillin and first generation cephalosporins. Also, it may be recommended to take either ciprofloxacin or ceftriaxone in combination with doxycycline though studies have shown no difference between the monotherapy and the combination105,106

IM, intramuscular; IV, intravenous.

Sharks

Since the 1990s, there have been 5034 shark attacks reported worldwide and 1205 of these incidents were fatal (22.7%).107 Most incidents occurred in North America (36.7%) and Australia (26.5%).107 Commonly affected populations include males, Whites, and those of middle age.108 Presentation often involves the legs (41.8%) and arms (18.4%), with limb loss documented in 7% of attacks.107 However, most patients sustain only minor injuries that can be primarily repaired.109 Limb losses greater than 20 cm and soft-tissue lacerations to more than one myofascial compartment are associated with higher morbidity.109 Treatment for these injuries follows the principles of debridement and reconstruction.110112

Alligators and Crocodiles

From 1928 until 2009, 567 reports of alligator attacks have been documented in the United States, with 24 resulting in death.113 The population most affected are those of middle age, with a median of 31.8 years, for both Australian and American alligator attacks.114 Most injuries reported have occurred while swimming or wading in shallow water at night.115 They commonly present as a result of penetrating, blunt and shear forces, ranging from minor scratches and punctures to amputations and death, with deep punctures being the initial and most common presentation.114,115 The severity of presentation is often linked to alligator size.115 Injury is often to the extremities, accounting for 80% of the largest series of Nile crocodile reports and 88% in the largest series of alligator injury reports.114

Initial treatment often includes extensive surgical cleaning and debridement,111,112 obtaining wound cultures, and administration of antitetanus treatment and broad-spectrum antibiotics.115,116 Significant hemorrhage should be controlled with direct pressure and wound packing.114 Radiographs should be obtained in the case of suspect bone fracture or retained foreign bodies.114,117 Devitalized tissue should be debrided and the remaining wound site should be left to heal by secondary intention or delayed primary closure.115,117 Most complications are related to serious deformities, reported in 40% of patients, but necrotizing soft-tissue infections and death have also been cited.115117 Common pathogens and treatments are presented in Table 8.

Table 8.

Common Pathogens and Subsequent Treatment of Horse Bites

Pathogen Recommended Treatment Timing Route of Administration Dosage Notes
Actinobacillus ligniseresii 118,119 Combination of tetracycline or streptomycin and potassium iodide 3 wk administration of both potassium iodide and tetracycline/streptomycin Oral or IV for potassium iodide + IM for streptomycin Potassium iodide: 6–10 g oral or 8 g/kg IV + streptomycin: 30 mg/kg/d for children; 2 g/d for adults119 This organism is extremely rare in humans
Potassium iodide: daily
Streptomycin: 2 daily doses; one dose every 12 h118
Streptococcus anginosus 120 Vancomycin 2 times a day; 1 dose every 12 h IV injection 15 mg/kg Penicillin and clindamycin have begun to show resistance
Streptococcus mutans 121 Ampicillin122 Every 6 h Oral 50–100 mg/kg/d for children; 250–500 mg for adults Various drugs could work such as cefotaxime, but ampicillin has shown best results. Intravenous and intramuscular injection is also possible
Campylobacter ureolyticus 123,124 Azithromycin123 Daily for 3–10 d as necessary Typically oral 500 mg Campylobacter has shown fluroquinolone resistance in some populations. Contraindicated if patient presents with liver or kidney issues124
Prevotella melaninogenica 125 Metronidazole126 Every 6 h for 7–10 d as necessary Typically oral 7.5 mg/kg There are many combinations that are possible to treat this bacteria
Beta-lactam44 (eg, penicillin) + beta-lactamase inhibitors44 (eg, tazobactam)
Bacteroides fragilis 127 Metronidazole126 Every 6 h for 7–10 d as necessary Typically oral 7.5 mg/kg This bacterial is resistant to penicillin. Although there have been increasing reports of resistance to metronidizole, it is still the favored treatment
Pasteurella caballi 128 Ampicillin122 Every 6 h Oral 50–100 mg/kg/d for children; 250–500 mg for adults There are many possible drug options but has shown the least amount of resistance
Yersinia pestis 63 Streptomycin 2 daily doses; one dose every 12 h IM 30 mg/kg/d for children; 2 g/d for adults
Gentamicin

IM, intramuscular; IV, intravenous.

Spiders

Although there are no definitive data on the occurrence of spider bites, many that can cause medically relevant harm to humans are rare and typically secluded to certain regions in Australia, except for the widow spider (Latrodectus), which has over 30 species.129,130 The venom produced by these spiders has been shown to cause long-lasting systemic and regional pain, patchy paralysis, agitation, hypertension, among other symptoms.131 Treatment historically consisted of calcium derivates geared to relax muscle, which have since shown to be ineffective.132,133 A combination of antibody-derived antivenom is now the preferred treatment, although one major study showed a significant reduction in pain for 48 hours using antivenom,133 whereas another major study showed no improvement in pain.134 Moreover, there seems to be no difference between administering the antivenom intravenously (IV) or intramuscularly (IM),132 but the literature is sparse. More data are needed to reach a formal conclusion regarding antivenom efficacy. Also, antivenom is expensive and harder to attain so it may not be accessible in resource-limited settings. Analgesics are typically used and have demonstrated effectiveness toward limiting pain and should be the primary method of treatment.

DISCUSSION

Animal bites are a common cause of medical visits worldwide; familiarity with the clinical presentations and complications of animal bites allows the clinician to better treat these bites. The presentation of injuries is broad, and the appropriate treatment is predicated on both the characteristics of the inciting animal and the patient. Most animal bites can be treated with supportive care, though some require more invasive surgical debridement and reconstruction. This article synthesizes pertinent information regarding the incidence, common presentation, initial treatment, and potential complications associated with dogs, cats, horses, rodents, snakes, marine life, and spider bites.

It cannot be ignored that many of the suggested treatments and protocols are not as easily administered in low- and middle-income countries and resource-limited settings. The issues mainly stem from limitations of ideal and proper treatment due to cost, distribution, and awareness of specific treatment modalities.2934,135 Although efforts should be made to increase the availability of novel treatments and patient education, utilization of basic supportive care can be implemented and is a powerful tool in resource-limited settings. Initial irrigation,19 debridement, and wound culture are often inexpensive and are a common indication in the management of many bites. Irrigating the wound with saline is an effective and readily accessible initial treatment for bite wounds.136 This should be followed by clinical assessment of the wound to determine the depth and extent of the wound; radiology studies may be required if there is clinical concern for fractures.136 Common antibiotics are indicated for many of the most common pathogens found in bite wounds; this may be directed by culture data as available. For rarer bites such as snake bites, if antivenom is not available, removing jewelry, placing the patient in the recovery position, and applying a pressure immobilization bandage are all inexpensive treatment methods.137,138 Supportive treatment options should be prioritized for animal bites as these are cost-effective and can be provided in resource-limited settings.

This review article is limited due to the few high-quality studies published on animal bites. This especially applies to more rare animal bites such as spider bites. In the studies identified, sample sizes are generally small, limiting generalizability. An additional limitation is the non-English language exclusion criteria, which restricts our analysis to a largely high-income country population, limiting generalizability to resource-limited settings.

Footnotes

Published online 9 September 2021.

Disclosure: Dr. Janis received royalties from Thieme and Springer Publishing. The other authors have no financial interest to declare.

REFERENCES

  • 1.Hurt JB, Maday KR. Management and treatment of animal bites. JAAPA Off J Am Acad Physician Assist. 2018;31:27–31. [DOI] [PubMed] [Google Scholar]
  • 2.Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cook JA, Sasor SE, Soleimani T, et al. An epidemiological analysis of pediatric dog bite injuries over a decade. J Surg Res. 2019;246:231–235. [DOI] [PubMed] [Google Scholar]
  • 4.Quirk JT. Non-fatal dog bite injuries in the U.S.A., 2005-2009. Public Health. 2012;126:300–302. [DOI] [PubMed] [Google Scholar]
  • 5.Basco AN, McCormack ER, Basco WT, Jr. Age- and sex-related differences in nonfatal dog bite injuries among persons aged 0-19 treated in hospital emergency departments, United States, 2001-2017. Public Health Rep. 2020;135:238–244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lyu C, Jewell MP, Piron J, et al. Burden of bites by dogs and other animals in Los Angeles County, California, 2009-2011. Public Health Rep Wash DC 1974. 2016;131:800–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zhang Y, Zhao Q, Zhang W, et al. Are hospital emergency department visits due to dog bites associated with ambient temperature? A time-series study in Beijing, China. Sci Total Environ. 2017;598:71–76. [DOI] [PubMed] [Google Scholar]
  • 8.Mair J, Duncan-Sutherland N, Moaveni Z. The incidence and risk factors of dog bite injuries requiring hospitalisation in New Zealand. N Z Med J. 2019;132:8–14. [PubMed] [Google Scholar]
  • 9.Schalamon J, Ainoedhofer H, Singer G, et al. Analysis of dog bites in children who are younger than 17 years. Pediatrics. 2006;117:e374–e379. [DOI] [PubMed] [Google Scholar]
  • 10.Avner JR, Baker MD. Dog bites in urban children. Pediatrics. 1991;88:55–57. [PubMed] [Google Scholar]
  • 11.Bula-Rudas FJ, Olcott JL. Human and animal bites. Pediatr Rev. 2018;39:490–500. [DOI] [PubMed] [Google Scholar]
  • 12.Fein J, Bogumil D, Upperman JS, et al. Pediatric dog bites: a population-based profile. Inj Prev. 2019;25:290–294. [DOI] [PubMed] [Google Scholar]
  • 13.Ramgopal S, Brungo LB, Bykowski MR, et al. Dog bites in a U.S. county: age, body part and breed in paediatric dog bites. Acta Paediatr. 2018;107:893–899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Smith AM, Carlson J, Bartels AB, et al. Characteristics of dog bites in Arkansas. South Med J. 2018;111:494–500. [DOI] [PubMed] [Google Scholar]
  • 15.Reisner IR, Nance ML, Zeller JS, et al. Behavioural characteristics associated with dog bites to children presenting to an urban trauma centre. Inj Prev. 2011;17:348–353. [DOI] [PubMed] [Google Scholar]
  • 16.Chen E, Hornig S, Shepherd SM, et al. Primary closure of mammalian bites. Acad Emerg Med. 2000;7:157–161. [DOI] [PubMed] [Google Scholar]
  • 17.Speirs J, Showery J, Abdou M, et al. Dog bites to the upper extremity in children. J Paediatr Child Health. 2015;51:1172–1174. [DOI] [PubMed] [Google Scholar]
  • 18.Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14:244–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Janis JE, Schoenbrunner AR, Saeg F. Evidence-based wound irrigation: separating fact from fiction. Plast Reconstr Surg. 2021. Accepted. [DOI] [PubMed] [Google Scholar]
  • 20.Rui-feng C, Li-song H, Ji-bo Z, et al. Emergency treatment on facial laceration of dog bite wounds with immediate primary closure: a prospective randomized trial study. BMC Emerg Med. 2013;13(suppl 1):S2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Paschos NK, Makris EA, Gantsos A, et al. Primary closure versus non-closure of dog bite wounds. A randomised controlled trial. Injury. 2014;45:237–240. [DOI] [PubMed] [Google Scholar]
  • 22.Xiaowei Z, Wei L, Xiaowei H, et al. Comparison of primary and delayed wound closure of dog-bite wounds. Vet Comp Orthop Traumatol. 2013;26:204–207. [DOI] [PubMed] [Google Scholar]
  • 23.Bower MG. Managing dog, cat, and human bite wounds. Nurse Pract. 2001;26:36–38, 41,–42, 45. [DOI] [PubMed] [Google Scholar]
  • 24.Dire DJ, Hogan DE, Walker JS. Prophylactic oral antibiotics for low-risk dog bite wounds. Pediatr Emerg Care. 1992;8:194–199. [DOI] [PubMed] [Google Scholar]
  • 25.Sandoe JAT. Capnocytophaga canimorsus endocarditis. J Med Microbiol. 2004;53(Pt 3):245–248. [DOI] [PubMed] [Google Scholar]
  • 26.Jaindl M, Grünauer J, Platzer P, et al. The management of bite wounds in children–a retrospective analysis at a level I trauma centre. Injury. 2012;43:2117–2121. [DOI] [PubMed] [Google Scholar]
  • 27.Qi L, Su K, Shen T, et al. Epidemiological characteristics and post-exposure prophylaxis of human rabies in Chongqing, China, 2007-2016. BMC Infect Dis. 2018;18:6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gautret P, Adehossi E, Soula G, et al. Rabies exposure in international travelers: do we miss the target? Int J Infect Dis. 2010;14:e243–e246. [DOI] [PubMed] [Google Scholar]
  • 29.Prasad VS, Duggal M, Aggarwal AK, et al. Animal bite management practices: a survey of health care providers in a community development block of Haryana. J Commun Dis. 2001;33:266–273. [PubMed] [Google Scholar]
  • 30.Ogundare EO, Olatunya OS, Oluwayemi IO, et al. Pattern and outcome of dog bite injuries among children in Ado-Ekiti, Southwest Nigeria. Pan Afr Med J. 2017;27:81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Salve H, Rizwan SA, Kant S, et al. Pre-treatment practices among patients attending an animal bite management clinic at a primary health centre in Haryana, North India. Trop Doct. 2015;45:123–125. [DOI] [PubMed] [Google Scholar]
  • 32.Tarantola A, Blanchi S, Cappelle J, et al. Rabies postexposure prophylaxis noncompletion after dog bites: estimating the unseen to meet the needs of the underserved. Am J Epidemiol. 2018;187:306–315. [DOI] [PubMed] [Google Scholar]
  • 33.Ngugi JN, Maza AK, Omolo OJ, et al. Epidemiology and surveillance of human animal-bite injuries and rabies post-exposure prophylaxis, in selected counties in Kenya, 2011-2016. BMC Public Health. 2018;18:996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.De Nardo P, Gentilotti E, Vairo F, et al. A retrospective evaluation of bites at risk of rabies transmission across 7 years: the need to improve surveillance and reporting systems for rabies elimination. PLoS One. 2018;13:e0197996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Teena MJ, Mathew T, Anish TS, et al. Post-exposure prophylaxis against rabies at two newly designated intradermal rabies vaccination clinics in Kerala, India. Natl Med J India. 2012;25:268–270. [PubMed] [Google Scholar]
  • 36.Gebru G, Romha G, Asefa A, et al. Risk factors and spatio-temporal patterns of human rabies exposure in Northwestern Tigray, Ethiopia. Ann Glob Health. 2019;85:119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ramesh Masthi NR, Pradeep BS, Bilagumba G. A multicentric community survey on animal exposures among humans in India. Indian J Public Health. 2019;63(suppl):S9–S14. [DOI] [PubMed] [Google Scholar]
  • 38.Nygaard M, Dahlin LB. Dog bite injuries to the hand. J Plast Surg Hand Surg. 2011;45:96–101. [DOI] [PubMed] [Google Scholar]
  • 39.Calkins CM, Bensard DD, Partrick DA, et al. Life-threatening dog attacks: a devastating combination of penetrating and blunt injuries. J Pediatr Surg. 2001;36:1115–1117. [DOI] [PubMed] [Google Scholar]
  • 40.Pédrono G, Ricard C, Bouilly M, et al. Assessment of 16-month sequelae due to dog bites originally studied in a French multicenter survey from 2009 to 2011. Wounds. 2018;30:84–89. [PubMed] [Google Scholar]
  • 41.Prendes MA, Jian-Amadi A, Chang SH, et al. Ocular trauma from dog bites: characterization, associations, and treatment patterns at a regional level I trauma center over 11 years. Ophthalmic Plast Reconstr Surg. 2016;32:279–283. [DOI] [PubMed] [Google Scholar]
  • 42.Tu AH, Girotto JA, Singh N, et al. Facial fractures from dog bite injuries. Plast Reconstr Surg. 2002;109:1259–1265. [DOI] [PubMed] [Google Scholar]
  • 43.Savar A, Kirszrot J, Rubin PA. Canalicular involvement in dog bite related eyelid lacerations. Ophthalmic Plast Reconstr Surg. 2008;24:296–298. [DOI] [PubMed] [Google Scholar]
  • 44.Pandey N, Cascella M. Beta Lactam Antibiotics. Treasure Island, Fla.: StatPearls Publishing; 2020. Available at http://www.ncbi.nlm.nih.gov/books/NBK545311/. Accessed January 7, 2021. [PubMed] [Google Scholar]
  • 45.Bregman B, Slavinski S. Using emergency department data to conduct dog and animal bite surveillance in New York City, 2003-2006. Public Health Rep. 2012;127:195–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Emet M, Beyhun NE, Kosan Z, et al. Animal-related injuries: epidemiological and meteorological features. Ann Agric Environ Med. 2009;16:87–92. [PubMed] [Google Scholar]
  • 47.Mendoza K, Benkouiten S, Brouqui P, et al. Epidemiology of injuries caused by mammals treated in emergency departments in Marseille, France. Wounds. 2015;27:253–257. [PubMed] [Google Scholar]
  • 48.Ostanello F, Gherardi A, Caprioli A, et al. Incidence of injuries caused by dogs and cats treated in emergency departments in a major Italian city. Emerg Med J. 2005;22:260–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Palacio J, León-Artozqui M, Pastor-Villalba E, et al. Incidence of and risk factors for cat bites: a first step in prevention and treatment of feline aggression. J Feline Med Surg. 2007;9:188–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Matter HC, Arbeitsgemeinschaft S. The epidemiology of bite and scratch injuries by vertebrate animals in Switzerland. Eur J Epidemiol. 1998;14:483–490. [DOI] [PubMed] [Google Scholar]
  • 51.Kravetz JD, Federman DG. Cat-associated zoonoses. Arch Intern Med. 2002;162:1945–1952. [DOI] [PubMed] [Google Scholar]
  • 52.Kwo S, Agarwal JP, Meletiou S. Current treatment of cat bites to the hand and wrist. J Hand Surg Am. 2011;36:152–153. [DOI] [PubMed] [Google Scholar]
  • 53.Wright JC. Reported cat bites in Dallas: characteristics of the cats, the victims, and the attack events. Public Health Rep. 1990;105:420–424. [PMC free article] [PubMed] [Google Scholar]
  • 54.Patrick GR, O’Rourke KM. Dog and cat bites: epidemiologic analyses suggest different prevention strategies. Public Health Rep. 1998;113:252–257. [PMC free article] [PubMed] [Google Scholar]
  • 55.Chen Y, Gao Y, Zhou L, et al. A comparative study of dog- and cat-induced injury on incidence and risk factors among children. Int J Environ Res Public Health. 2016;13:E1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Westling K, Farra A, Cars B, et al. Cat bite wound infections: a prospective clinical and microbiological study at three emergency wards in Stockholm, Sweden. J Infect. 2006;53:403–407. [DOI] [PubMed] [Google Scholar]
  • 57.Kheiran A, Palial V, Rollett R, et al. Cat bite: an injury not to underestimate. J Plast Surg Hand Surg. 2019;53:341–346. [DOI] [PubMed] [Google Scholar]
  • 58.Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med. 1999;340:85–92. [DOI] [PubMed] [Google Scholar]
  • 59.Babovic N, Cayci C, Carlsen BT. Cat bite infections of the hand: assessment of morbidity and predictors of severe infection. J Hand Surg Am. 2014;39:286–290. [DOI] [PubMed] [Google Scholar]
  • 60.Pomares G, Huguet S, Dap F, et al. Contaminated wounds: effectiveness of debridement for reducing bacterial load. Hand Surg Rehabil. 2016;35:266–270. [DOI] [PubMed] [Google Scholar]
  • 61.Garcia VF. Animal bites and Pasturella infections. Pediatr Rev. 1997;18:127–130. [DOI] [PubMed] [Google Scholar]
  • 62.Jacobs RF. Francisella tularensis (Tularemia)—infectious disease and antimicrobial agents. Available at http://www.antimicrobe.org/b79.asp. Accessed January 7, 2021.
  • 63.Poland JD, Dennis DT. Treatment of plague. Available at https://www.who.int/csr/resources/publications/plague/whocdscsredc992b.pdf. Accessed January 7, 2021.
  • 64.CDC. Sporotrichosis. Fungal siseases. 2020. Available at https://www.cdc.gov/fungal/diseases/sporotrichosis/index.html. Accessed January 7, 2021.
  • 65.Klotz SA, Ianas V, Elliott SP. Cat-scratch disease. Am Fam Physician. 2011;83:152–155. [PubMed] [Google Scholar]
  • 66.Janis JE, Schoenbrunner AR, Russell J. Comprehensive management of snakebites. Plast Reconstr Surg. Submitted. [Google Scholar]
  • 67.Russell J, Schoenbrunner AR, Janis JE. Snake bite management: a scoping review of the literature. Plast Reconstr Surg. 2021;9:e3506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Bisneto PF, Alcântara JA, Mendonça da Silva I, et al. Coral snake bites in Brazilian Amazonia: perpetrating species, epidemiology and clinical aspects. Toxicon. 2020;175:7–18. [DOI] [PubMed] [Google Scholar]
  • 69.Ediriweera DS, Kasthuriratne A, Pathmeswaran A, et al. Adjusting for spatial variation when assessing individual-level risk: a case-study in the epidemiology of snake-bite in Sri Lanka. PLoS One. 2019;14:e0223021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Magalhães SFV, Peixoto HM, de Almeida Gonçalves Sachett J, et al. Snakebite envenomation in the Brazilian Amazon: a cost-of-illness study. Trans R Soc Trop Med Hyg. 2020;114:635–642. [DOI] [PubMed] [Google Scholar]
  • 71.Gajbhiye R, Khan S, Kokate P, et al. Incidence & management practices of snakebite: a retrospective study at Sub-District Hospital, Dahanu, Maharashtra, India. Indian J Med Res. 2019;150:412–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.El Hattimy F, Chafiq F, Hami H, et al. Geographical distribution of health indicators related to snake bites and envenomation in Morocco between 1999 and 2013. Epidemiol Health. 2018;40:e2018024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Harmon KJ, Haskell MG, Mann CH, et al. Snakebites treated in North Carolina Emergency Departments, October 2013-September 2015. Wilderness Environ Med. 2018;29:176–184. [DOI] [PubMed] [Google Scholar]
  • 74.Musah Y, Ameade EPK, Attuquayefio DK, et al. Epidemiology, ecology and human perceptions of snakebites in a savanna community of northern Ghana. Plos Negl Trop Dis. 2019;13:e0007221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Ruha AM, Kleinschmidt KC, Greene S, et al. ; ToxIC Snakebite Study Group. The epidemiology, clinical course, and management of snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13:309–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Schulte J, Domanski K, Smith EA, et al. Childhood victims of snakebites: 2000-2013. Pediatrics. 2016;138:e20160491. [DOI] [PubMed] [Google Scholar]
  • 77.Roriz KRPS, Zaqueo KD, Setubal SS, et al. Epidemiological study of snakebite cases in Brazilian Western Amazonia. Rev Soc Bras Med Trop. 2018;51:338–346. [DOI] [PubMed] [Google Scholar]
  • 78.Narvencar K, Favas TT, Dias A. Epidemiology and clinical profile of snakebites in Goa and Surrounding Areas. J Assoc Physicians India. 2020;68:28–32. [PubMed] [Google Scholar]
  • 79.Karabuva S, Vrkić I, Brizić I, et al. Venomous snakebites in children in southern Croatia. Toxicon. 2016;112:8–15. [DOI] [PubMed] [Google Scholar]
  • 80.Nishioka Sde A, Silveira PV, Bauab FA. Bite marks are useful for the differential diagnosis of snakebite in Brazil. Wilderness Environ Med. 1995;6:183–188. [DOI] [PubMed] [Google Scholar]
  • 81.Tan HH. Epidemiology of snakebites from a general hospital in Singapore: a 5-year retrospective review (2004-2008). Ann Acad Med Singap. 2010;39:640–647. [PubMed] [Google Scholar]
  • 82.Adukauskienė D, Varanauskienė E, Adukauskaitė A. Venomous snakebites. Medicina (Kaunas). 2011;47:461–467. [PubMed] [Google Scholar]
  • 83.Europe PMC. Presentation and management of venomous snakebites: should all patients be transferred to a tertiary referral hospital? Abstract. Available at https://europepmc.org/article/med/27518288. Accessed January 7, 2021. [PubMed]
  • 84.Avau B, Borra V, Vandekerckhove P, et al. The treatment of snake bites in a first aid setting: a systematic review. Plos Negl Trop Dis. 2016;10:e0005079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Snow RW, Bronzan R, Roques T, et al. The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population. Ann Trop Med Parasitol. 1994;88:665–671. [DOI] [PubMed] [Google Scholar]
  • 86.Sharma SK, Koirala S, Dahal G, et al. Clinico-epidemiological features of snakebite: a study from Eastern Nepal. Trop Doct. 2004;34:20–22. [DOI] [PubMed] [Google Scholar]
  • 87.da Silva Souza A, de Almeida Gonçalves Sachett J, Alcântara JA, et al. Snakebites as cause of deaths in the Western Brazilian Amazon: why and who dies? Deaths from snakebites in the Amazon. Toxicon. 2018;145:15–24. [DOI] [PubMed] [Google Scholar]
  • 88.Holve S. Venomous spiders, snakes, and scorpions in the United States. Pediatr Ann. 2009;38:210–217. [PubMed] [Google Scholar]
  • 89.Gnanathasan A, Rodrigo C. Pulmonary effects and complications of snakebites. Chest. 2014;146:1403–1412. [DOI] [PubMed] [Google Scholar]
  • 90.Heise CW, Ruha AM, Padilla-Jones A, et al. Clinical predictors of tissue necrosis following rattlesnake envenomation. Clin Toxicol (Phila). 2018;56:281–284. [DOI] [PubMed] [Google Scholar]
  • 91.Li W, Chen F, Wu S. The related risk factors analysis of snake-bite induced acute kidney injury. Med Sci Monit. 2016;22:2335–2339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Tekin R, Sula B, Cakirca G, et al. Comparison of snakebite cases in children and adults. Eur Rev Med Pharmacol Sci. 2015;19:2711–2716. [PubMed] [Google Scholar]
  • 93.Winchester Hospital. Gram-negative bacterial infection. Available at https://www.winchesterhospital.org/health-library/article?id=936788. Accessed January 7, 2021.
  • 94.Abrahamian FM, Goldstein EJ. Microbiology of animal bite wound infections. Clin Microbiol Rev. 2011;24:231–246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Hirschhorn RB, Hodge RR. Identification of risk factors in rat bite incidents involving humans. Pediatrics. 1999;104:e35. [DOI] [PubMed] [Google Scholar]
  • 96.Sliman R, Rehm S, Shlaes DM. Serious infections caused by Bacillus species. Medicine (Baltimore). 1987;66:218–223. [DOI] [PubMed] [Google Scholar]
  • 97.Clindamycin: MedlinePlus drug information. Available at https://medlineplus.gov/druginfo/meds/a682399.html. Accessed January 7, 2021.
  • 98.Drugs.com. Clindamycin dosage guide with precautions. Available at https://www.drugs.com/dosage/clindamycin.html. Accessed January 7, 2021.
  • 99.Drugs.com. Vancomycin dosage guide with precautions. Available at https://www.drugs.com/dosage/vancomycin.html. Accessed January 7, 2021.
  • 100.Elliott SP. Rat bite fever and Streptobacillus moniliformis. Clin Microbiol Rev. 2007;20:13–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Köse R, Söğüt Ö, Mordeniz C. Management of horse and donkey bite wounds: a series of 24 cases. Plast Reconstr Surg. 2010;125:251e–252e. [DOI] [PubMed] [Google Scholar]
  • 102.Mensa J, Barberán J, Soriano A, et al. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: guidelines by the Spanish Society of Chemotherapy. Rev Esp Quimioter. 2018;31:78–100. [PMC free article] [PubMed] [Google Scholar]
  • 103.Medscape. Zosyn, (piperacillin-tazobactam) dosing, indications, interactions, adverse effects, and more. Available at https://reference.medscape.com/drug/zosyn-piperacillin-tazobactam-342485. Accessed January 8, 2021.
  • 104.Pseudomonas aeruginosa. Available at http://www.antimicrobe.org/b112.asp. Accessed January 8, 2021.
  • 105.Stevens DL, Bisno AL, Chambers HF, et al. ; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–e52. [DOI] [PubMed] [Google Scholar]
  • 106.Doryx Information Sheet. June 2008. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050795s005lbl.pdf. Accessed January 8, 2021.
  • 107.Ricci JA, Vargas CR, Singhal D, et al. Shark attack-related injuries: epidemiology and implications for plastic surgeons. J Plast Reconstr Aesthet Surg. 2016;69:108–114. [DOI] [PubMed] [Google Scholar]
  • 108.Tomberg RJ, Cachaper GA, Weingart GS. Shark related injuries: a case series of emergency department patients. Am J Emerg Med. 2018;36:1645–1649. [DOI] [PubMed] [Google Scholar]
  • 109.Woolgar JD, Cliff G, Nair R, et al. Shark attack: review of 86 consecutive cases. J Trauma. 2001;50:887–891. [DOI] [PubMed] [Google Scholar]
  • 110.Janis JE, Kwon RK, Attinger CE. The new reconstructive ladder: modifications to the traditional model. Plast Reconstr Surg. 2011;127(suppl 1):205S–212S. [DOI] [PubMed] [Google Scholar]
  • 111.Attinger CE, Evans KK, Bulan E, et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg. 2006;117(7 suppl):261S–293S. [DOI] [PubMed] [Google Scholar]
  • 112.Anghel EL, DeFazio MV, Barker JC, et al. Current concepts in debridement: science and strategies. Plast Reconstr Surg. 2016;138(3 suppl):82S–93S. [DOI] [PubMed] [Google Scholar]
  • 113.Langley RL. Adverse encounters with alligators in the United States: an update. Wilderness Environ Med. 2010;21:156–163. [DOI] [PubMed] [Google Scholar]
  • 114.Caldicott DG, Croser D, Manolis C, et al. Crocodile attack in Australia: an analysis of its incidence and review of the pathology and management of crocodilian attacks in general. Wilderness Environ Med. 2005;16:143–159. [DOI] [PubMed] [Google Scholar]
  • 115.Mekisic AP, Wardill JR. Crocodile attacks in the Northern Territory of Australia. Med J Aust. 1992;157:751–754. [DOI] [PubMed] [Google Scholar]
  • 116.Wamisho BL, Bates J, Tompkins M, et al. Ward round–crocodile bites in Malawi: microbiology and surgical management. Malawi Med J. 2009;21:29–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Howard RJ, Burgess GH. Surgical hazards posed by marine and freshwater animals in Florida. Am J Surg. 1993;166:563–567. [DOI] [PubMed] [Google Scholar]
  • 118.Orda R, Wiznitzer T. Actinobacillus lignieresii human infection. J R Soc Med. 1980;73:295–297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.ACTINOBACILLOSIS (Wooden Tongue). Available at http://lrd.spc.int/ext/Disease_Manual_Final/actinobacillosis_wooden_tongue.html. Accessed January 8, 2021.
  • 120.Wenzler E, Chandrasekaran V, Salvador P, et al. Clinical and microbiological outcomes in patients with Streptococcus anginosus group bacteraemia identified through use of a rapid microarray assay. J Med Microbiol. 2015;64:1369–1374. [DOI] [PubMed] [Google Scholar]
  • 121.Saputo S, Faustoferri RC, Quivey RG, Jr. Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system. Antimicrob Agents Chemother. 2018;62:e01675–e01617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.RxList. Ampicillin: side effects, dosages, treatment, interactions, warnings. Available at https://www.rxlist.com/consumer_ampicillin_penicillin/drugs-condition.htm. Accessed January 8, 2021.
  • 123.nhs.uk. Azithromycin: antibiotic to treat bacterial infections. 2018. Available at https://www.nhs.uk/medicines/azithromycin/. Accessed January 8, 2021.
  • 124.Campylobacter infections medication: antibiotics. Available at https://emedicine.medscape.com/article/213720-medication. Accessed January 8, 2021.
  • 125.Finegold SM. Anaerobic gram-negative bacilli. Baron S, ed. In: Medical Microbiology. 4th ed. University of Texas Medical Branch at Galveston; 1996. Available at http://www.ncbi.nlm.nih.gov/books/NBK8438/. Accessed January 8, 2021. [PubMed] [Google Scholar]
  • 126.Mayo Clinic. Metronidazole (oral route) proper use. Available at https://www.mayoclinic.org/drugs-supplements/metronidazole-oral-route/proper-use/drg-20064745. Accessed January 8, 2021.
  • 127.Elsaghir H, Reddivari AKR. Bacteroides Fragilis. StatPearls Publishing; 2020. Available at http://www.ncbi.nlm.nih.gov/books/NBK553032/. Accessed January 8, 2021. [PubMed] [Google Scholar]
  • 128.Schlater LK, Brenner DJ, Steigerwalt AG, et al. Pasteurella caballi, a new species from equine clinical specimens. J Clin Microbiol. 1989;27:2169–2174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Dominguez TJ. It’s not a spider bite, it’s community-acquired methicillin-resistant Staphylococcus aureus. J Am Board Fam Pract. 2004;17:220–226. [DOI] [PubMed] [Google Scholar]
  • 130.Williams M, Anderson J, Nappe TM. Black Widow Spider Toxicity. Treasure Island, Fla.: StatPearls Publishing; 2020. Available at http://www.ncbi.nlm.nih.gov/books/NBK499987/. Accessed January 8, 2021. [PubMed] [Google Scholar]
  • 131.Ryan NM, Buckley NA, Graudins A. Treatments for latrodectism-A systematic review on their clinical effectiveness. Toxins (Basel). 2017;9:E148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Isbister GK, Gray MR. Latrodectism: a prospective cohort study of bites by formally identified redback spiders. Med J Aust. 2003;179:88–91. [DOI] [PubMed] [Google Scholar]
  • 133.Dart RC, Bush SP, Heard K, et al. The Efficacy of antivenin latrodectus (black widow) equine immune F(ab’)2 versus placebo in the treatment of latrodectism: a randomized, double-blind, placebo-controlled, clinical trial. Ann Emerg Med. 2019;74:439–449. [DOI] [PubMed] [Google Scholar]
  • 134.Isbister GK, Page CB, Buckley NA, et al. ; RAVE Investigators. Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study. Ann Emerg Med. 2014;64:620–8.e2. [DOI] [PubMed] [Google Scholar]
  • 135.Barbosa Costa G, Gilbert A, Monroe B, et al. The influence of poverty and rabies knowledge on healthcare seeking behaviors and dog ownership, Cameroon. PLoS One. 2018;13:e0197330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Ellis R, Ellis C. Dog and cat bites. Am Fam Physician. 2014;90:239–243. [PubMed] [Google Scholar]
  • 137.nhs.uk. First aid - recovery position. 2017. Available at https://www.nhs.uk/conditions/first-aid/recovery-position/. Accessed February 12, 2021.
  • 138.Cleveland Clinic. Snake bite: symptoms, causes, diagnosis & treatment. Available at https://my.clevelandclinic.org/health/diseases/15647-snake-bites. Accessed February 12, 2021.

Articles from Plastic and Reconstructive Surgery Global Open are provided here courtesy of Wolters Kluwer Health

RESOURCES